Hackensack Meridian Health

Clinical research site in Neptune City, New Jersey

As of July 2026, 1 paid clinical trial is recruiting at Hackensack Meridian Health in Neptune City, New Jersey. Active studies at this site cover conditions such as Berger Disease, Bergers Disease and IgA Nephropathy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Hackensack Meridian Health (1)

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

for Berger Disease

4 locations incl. Neptune City

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 18

Code: NCT07498335·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

More research sites in Neptune City

Jersey Shore University Medical Center (19 trials)
Jersey Shore Medical Center (16 trials)
HMH Jersey Shore University Medical Center (3 trials)
HOPE Tower at Jersey Shore University Medical Center (2 trials)
287 (1 trial)
Ep0162 50626 (1 trial)
Ep0165 50626 (1 trial)
HMH Jersey Shore University Medical Ctr. (1 trial)
Hackensack Meridian (1 trial)
Hackensack Meridian Health - Jersey Shore University Medical Center (1 trial)

Explore more

Paid clinical trials in Neptune City, NJ · New Jersey clinical trials